Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Qyuns Therapeutics (1822972D CH)
Watchlist
4
Analysis
Health Care
•
China
Qyuns Therapeutics Co., Ltd. develops and distributes medical drugs. The Company produces immune disease antibody drugs, monoclonal antibody drugs, and other products. Qyuns Therapeutics also operates import and export businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Qyuns Therapeutics
•
14 Mar 2024 08:55
Pre-IPO Qyuns Therapeutics (PHIP Updates) - Some Points Worth the Attention
Qyuns is overvalued due to gloomy commercialization outlook.Qyuns may even find it hard to recover the cost of pipeline. Investors could trade and...
Xinyao (Criss) Wang
Follow
294 Views
Share
bearish
•
Qyuns Therapeutics
•
30 Nov 2023 08:55
Pre-IPO Qyuns Therapeutics - Conservative About the Outlook
Qyuns’s pipeline lacks competitiveness, facing fierce competition.Together with bleak internationalization outlook, peak sales have obvious...
Xinyao (Criss) Wang
Follow
280 Views
Share
bearish
•
Qyuns Therapeutics
•
30 Oct 2023 14:56
Qyuns Therapeutics (荃信生物) Pre-IPO: Mixed View on Two Core Products
In this note, we look at fundamentals of Qyuns Therapeutics. We examined the two core products, QX002N and QX005N. We have mixed view on its...
Ke Yan, CFA, FRM
Follow
306 Views
Share
bullish
•
Wuxi Biologics
•
05 Nov 2023 08:25
ECM Weekly (5th Nov 2023)- Midea, WuxiXDC, Cello, Honasa, Qyuns, Ecopro, Lalatech, Mankind, TWE, VNT
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
Sumeet Singh
Follow
404 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x